Intellipharmaceutics: Fiscal 2Q Earnings Snapshot
TORONTO (AP) _ Intellipharmaceutics International Inc. (IPCIF) on Wednesday reported a loss of $2.1 million in its fiscal second quarter.
The Toronto-based company said it had a loss of 10 cents per share.
The extended-release drug developer posted revenue of $1.2 million in the period.
The company’s shares closed at 21 cents. A year ago, they were trading at $4.80.